,id,name,AB,description,OX,dataset,seq
antitb_1001,antitb_1001,Polydim-I ,1,"('Amphipathic', 'Cell wall disruption ', 'Cell wall')",6 to 8 weeks old BALB/c and IFN-Î³KO (Knockout) female mice ,AntiTbPdb.html,AVAGEKLWLLPHLLKMLLTPTP
antitb_1002,antitb_1002,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')","Female BALB/c mice, male CD-1 mice",AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1003,antitb_1003,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')","Female BALB/c mice, male CD-1 mice",AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1004,antitb_1004,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')","Female BALB/c mice, male CD-1 mice",AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1005,antitb_1005,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')","Female BALB/c mice, male CD-1 mice",AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1006,antitb_1006,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')","Female BALB/c mice, male CD-1 mice",AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1007,antitb_1007,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1008,antitb_1008,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1009,antitb_1009,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1010,antitb_1010,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1011,antitb_1011,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1012,antitb_1012,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1013,antitb_1013,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1014,antitb_1014,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1015,antitb_1015,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1016,antitb_1016,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1017,antitb_1017,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1018,antitb_1018,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1019,antitb_1019,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1020,antitb_1020,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1021,antitb_1021,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1022,antitb_1022,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1023,antitb_1023,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1024,antitb_1024,Ecumicin ,1,"('NA', 'Ecumicin markedly enhanced the ATPase activity of wild-type (WT) ClpC1 but prevented activation of proteolysis by ClpC1. so toxic proteins which are normally degraded by the ClpC1P1P2 complex, accumulate in the presence of ecumicin', 'ClpC1 ATPase complex ')",None,AntiTbPdb.html,"(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)"
antitb_1123,antitb_1123,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1124,antitb_1124,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1125,antitb_1125,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1126,antitb_1126,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1127,antitb_1127,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1128,antitb_1128,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1129,antitb_1129,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1130,antitb_1130,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1131,antitb_1131,PR-39,1,"('Amphipathic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
antitb_1134,antitb_1134,Protegrin-1 (PG-1),1,"('Cationic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RGGRLCYCRRRFCVCVGR
antitb_1135,antitb_1135,Protegrin-1 (PG-1),1,"('Cationic', 'Disrupt the membrane architecture', 'Cell envelope')",None,AntiTbPdb.html,RGGRLCYCRRRFCVCVGR
antitb_1144,antitb_1144,Nisin A,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1145,antitb_1145,Nisin A,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1146,antitb_1146,Nisin A,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1147,antitb_1147,Nisin A,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1148,antitb_1148,Nisin A,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1149,antitb_1149,Nisin V,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANVK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1150,antitb_1150,Nisin V,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANVK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1151,antitb_1151,Nisin V,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANVK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1152,antitb_1152,Nisin V,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANVK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1153,antitb_1153,Nisin V,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANVK-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1154,antitb_1154,Nisin S,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMS-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1155,antitb_1155,Nisin S,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMS-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1156,antitb_1156,Nisin S,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMS-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1157,antitb_1157,Nisin S,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMS-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
antitb_1158,antitb_1158,Nisin S,1,"('NA', 'NA', 'NA')",None,AntiTbPdb.html,I-(Dhb)-AI-(Dha)-LA-(Abu)-PGAK-(Abu)-GALMGANMS-(Abu)-A-(Abu)-ANASIHV-(Dha)-K
